Michael Herman

Michael R. Herman

MD at South Nassau Communities Hospital

Update Profile
1 HEALTHY WAY, Oceanside, New York, United States
HQ Phone:
(516) 632-3000

General Information


Applied Economics and Management  - Cornell University

President  - hermanmerchantservices.com

Effective Solutions For Your Business  - Herman Merchant Services - PayJunction


Southwestern Medical School

M.D.  - 

medical degree  - University of Texas Southwestern Medical Center

undergraduate degree  - Harvard University


Co-Founder  - Public Health Interest Group

Recent News  

Michael Herman, MD, director of urology at South Nassau, said the very latest techniques are being used at South Nassau to address issues like prostate cancer.
South Nassau is one of the only hospitals in Nassau County to offer MRI-Ultrasound Targeted Biopsy, an innovative new technology for more precise and accurate detection of prostate cancer. "We have the experience and resources so that most men with urologic health problems can maintain a healthy and vibrant life at any age," said Dr. Herman.

Read More

Michael P. Herman, MD, Director of the Urologic Oncology Program at South Nassau Communities Hospital and Daniel S. McCally, MD, FACS, Assistant Director of the Urology Program at South Nassau Communities Hospital, perform a prostate biopsy.
Dr. Herman and Edward Mullen, MD, Director of the Radiation Oncology Program, discuss prostate treatment planning for the Novalis Tx Radiosurgery System. "PSA levels can be elevated for reasons unrelated to prostate cancer, including the normal enlargement of the prostate that occurs over time, prostatitis or sexual activity," says Michael P. Herman, MD, Director of Urologic Oncology at South Nassau Communities Hospital. Both tests empower patients to make educated decisions alongside their physicians about the need for prostate biopsy, according to Dr. Herman. Advancements in Prostate Cancer Biopsy Prostate biopsy traditionally has involved taking up to 12 random samples of tissue from the prostate using transrectal ultrasound (TRUS) guidance. However, this technique can miss a significant number of cancers, according to Dr. Herman. In conjunction with the traditional biopsy technique, South Nassau Communities Hospital offers MRI/TRUS-fusion biopsy, which combines MRI and sonography to provide a virtual roadmap to prostate lesions. A 2015 study published in JAMA: The Journal of the American Medical Association found that, when compared with random biopsy, MRI/TRUS-fusion biopsy identified 30 percent more high-risk cancers and appears to better differentiate among low-, intermediate- and high-risk disease. "The information provided by the MRI allows us to biopsy tissue from areas of the prostate that are more likely to have disease," Dr. Herman says. "For many men, undetected prostate cancer would be asymptomatic and have no impact on longevity or quality of life," Dr. Herman says. Michael P. Herman, MD, Director of the Urologic Oncology Program, joined the South Nassau Communities Hospital team in July 2015 and brings specialized expertise in urologic oncology and robotic surgery. Dr. Herman completed his undergraduate degree at Harvard University and his medical degree at the University of Texas Southwestern Medical Center. His internship in general surgery and residencies in general surgery and urology were both performed at NewYork-Presbyterian Hospital. In addition to his appointment at South Nassau Communities Hospital, Dr. Herman is an assistant attending physician at NewYork-Presbyterian/Weill Cornell Medical Center. "With genomic testing, we can reassure men that their disease does not seem to be acting aggressively at the cellular level," Dr. Herman says. "Following removal of the prostate, physicians must reconstruct the bladder and the junction between the urethra and bladder," Dr. Herman says. Dr. Herman, seated at the da Vinci Si surgical console, prepares for a robotic prostatectomy. SNCH-Dr Herman Robotic Hands 750 Dr. Herman's hand movements are precisely mirrored by the robotic arms of the da Vinci Si Surgical System. - Michael P. Herman, MD, Director of Urologic Oncology at South Nassau Communities Hospital Dr. Herman and Powell discuss a patient's treatment protocol. "From robotic surgery to radiation therapy and cryosurgery, we can provide individualized, state-of-the-art treatment for patients with all stages of prostate cancer," Dr. Herman says.

Read More

Dr. Michael P. Herman is the Director of Urologic Oncology at South Nassau.
For more information on da Vinci Surgery, you may contact Dr. Herman at 516-632-3350 or visit www.southnassauroboticsurgery.org Michael P. Herman, MD - Director, Urologic Oncology: (516) 632-3350

Read More

Browse ZoomInfo’s Directories